Presumed Glioblastoma Multiforme: A Case for Biopsy Prior to Treatment.

@article{Staller2016PresumedGM,
  title={Presumed Glioblastoma Multiforme: A Case for Biopsy Prior to Treatment.},
  author={Aileen Staller},
  journal={Clinical journal of oncology nursing},
  year={2016},
  volume={20 1},
  pages={
          95-7
        }
}
  • A. Staller
  • Published 1 February 2016
  • Medicine
  • Clinical journal of oncology nursing
Glioblastoma multiforme (GBM) is the most lethal and aggressive primary brain tumor. Several other abnormalities (neoplastic, infectious, or vascular) can mimic symptoms seen with GBM. This article reviews GBM and presents a case study that demonstrates the rationale for biopsy and pathologic diagnosis prior to the initiation of treatment for malignant brain tumors. 
View on PubMed
brainlife.org
2 Citations
Background Citations
1

2 Citations

Citation Type

Citation Type

Human organotypic brain slice culture: a novel framework for environmental research in neuro-oncology
TLDR
A simple method to study glioblastoma in its physiological environment, from which valuable insights can be gained and can lead to further advancements in neuroscience, neuro-oncology, and pharmacotherapy.
The caspase-3/GSDME signal pathway as a switch between apoptosis and pyroptosis in cancer
TLDR
The caspase-3/GSDME signal pathway as a switch between apoptosis and pyroptosis in cancer is reviewed to provide new strategies and targets for cancer treatment.

References

SHOWING 1-10 OF 21 REFERENCES
Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma
TLDR
In 51 consecutive patients treated according to this regimen, 7 patients manifested surgically confirmed early necrosis without evidence of recurrent tumor, suggesting that daily TMZ may represent a potent radiosensitizing regimen.
Temozolomide in malignant gliomas: current use and future targets
TLDR
Developing concerns regarding the use of TMZ, imaging of malignant gliomas, and the pharmacology of TMZ—mechanism of action, scheduling and strategies for overcoming resistance are summarized.
Dose-intensity temozolomide after concurrent chemoradiotherapy in operated high-grade gliomas
TLDR
The toxicity of the TMZ dose-dense regimen was very low, and results seem to be encouraging for RPA lower classes (patients with good prognostic factors).
Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas.
TLDR
Data is summarized on incidence rates, survival, and genetic alterations from population-based studies of astrocytic and oligodendrogliomas that were carried out in the Canton of Zurich, Switzerland to suggest that the acquisition of TP53 mutations in these glioblastoma subtypes may occur through different mechanisms.
Temozolomide: a milestone in neuro-oncology and beyond?
TLDR
The benefit of temozolomide chemotherapy is restricted to patients whose tumors have a methylated methylguanine methyltransferase gene promotor and are thus unable to repair some of the chemotherapy-induced DNA damage.
Anopheles mosquito transmission of brain tumor.
Simian virus 40 in human cancers.
Robbins & Cotran Pathologic Basis of Disease
TLDR
The pathologic basis of disease is determined by X-ray diffraction analysis of the granuloma with an Higgs–Cotran–Bouchut–Seiden ratio of 3:1.
Dose‐dense temozolomide regimens
TLDR
Preclinical and clinical evidence suggests that temozolomide‐associated lymphodepletion may enhance the host immune response to tumor‐associated antigens and/or immunotherapy and may overcome tumor‐mediated immunosuppression.
Robbins and Cotran pathologic basis of disease
TLDR
Robbins and Cotan pathologic basis of disease / , Robbins and Cotran pathologicBased on X-ray diffraction analysis, autopsies showed clear trends in prognosis of central giant cell granuloma.
...
1
2
3
...